1. Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis 
Daniel Weisdorf, Mary Eapen, Annalisa Ruggeri, Mei-Jie Zhang, Xiaobo Zhong, Claudio Brunstein, Celalettin Ustun, Vanderson Rocha, Eliane Gluckman 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 6, Pages (June 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Treatment related mortality (*compared with 8/8 URD P < within 3 months of HCT; compared with 7/8 URD P < .001 beyond 3 months), leukemia-free survival, relapse, and survival after allogeneic HCT. Adjusted P values reflect the multivariate analyses shown in Table 3. * indicates P < compared with 8/8 HLA-matched URD.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions